Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Unknown × talactoferrin alfa × Thoracic × Clear all

Phase

Status

Completed 2 Unknown 1 Terminated 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Carcinoma, Non-Small-Cell Lung 1

Interventions

Carboplatin 133 Cisplatin 130 Pemetrexed 112 Docetaxel 79 Drug Therapy 60 Gefitinib 58 anlotinib 55 Gemcitabine 55 Erlotinib Hydrochloride 55 Radiotherapy 49 Bevacizumab 49 Paclitaxel 48 pembrolizumab 45 Etoposide 45 apatinib 42 icotinib 41 camrelizumab 40 osimertinib 35 Nivolumab 32 Vinorelbine 31 sintilimab 29 Radiosurgery 27 durvalumab 25 endostar protein 24 aumolertinib 24 Endostatins 22 atezolizumab 21 Blood Specimen Collection 21 toripalimab 18 Immune Checkpoint Inhibitors 18

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00706862 2012-03-15

FORTIS-C

Agennix

Phase 3 Unknown

Carcinoma, Non-Small-Cell Lung

Data powered by HemOnc (CC BY 4.0) Colophon ⚡